[beta-Amyloid, cholinergic neurons and Alzheimer's disease]
- PMID: 12053492
[beta-Amyloid, cholinergic neurons and Alzheimer's disease]
Abstract
Alzheimer's disease is the most common neurodegenerative disorder in men and its incidence increases with the prolongation of life expectancy. The late phase of the disease is accompanied by a failure of cognitive and mental functions. Post mortem examination of the brain reveals the presence of neuritic plaques and neurofibrillary tangles, particularly in the cortex and hippocampus, and a reduction of the number of cerebrocortical neurons. Biochemical changes include the affliction of various neurotransmitter systems with the obligatory damage of the basal forebrain cholinergic system. Understanding of the pathogeny of Alzheimer's disease and, consequently, of ways to its therapy is still quite limited, in spite of enormous effort by investigators. Advanced molecular biological and genetical approaches indicate that the primary cause of Alzheimer's disease is the accumulation and toxic action of beta-amyloid peptide, which is formed as a less common breakdown product of the amyloid precursor protein. In this review we briefly outline some recent ideas concerning the origin and progression of the disease, with the main focus on the metabolism of beta-amyloid and on possible mechanisms of its deleterious influence on the neuronal, particularly cholinergic cells. Two basic cytotoxic effects of beta-amyloid on neurons appear to be the disturbance of the homeostasis of intracellular calcium ions and the induction of oxidative stress, and they together bring about necrotic or apoptotic cell death. However, it has been found in experiments that the damage of cholinergic neurons and cholinergic neurotransmission can be induced by beta-amyloid at such low concentrations which do not yet evoke general cytotoxic effects. Weakening of cholinergic neurotransmission is known to result in an increase in the production of beta-amyloid, and the damage of cholinergic neurons thus seems to initiate a vicious circle which speeds up the progression of the disease.
Similar articles
-
Neuronal amyloid-β accumulation within cholinergic basal forebrain in ageing and Alzheimer's disease.Brain. 2015 Jun;138(Pt 6):1722-37. doi: 10.1093/brain/awv024. Epub 2015 Mar 1. Brain. 2015. PMID: 25732182 Free PMC article.
-
Basal forebrain cholinergic dysfunction in Alzheimer's disease--interrelationship with beta-amyloid, inflammation and neurotrophin signaling.Neurochem Res. 2005 Jun-Jul;30(6-7):895-908. doi: 10.1007/s11064-005-6962-9. Neurochem Res. 2005. PMID: 16187224 Review.
-
The cholinergic system in aging and neuronal degeneration.Behav Brain Res. 2011 Aug 10;221(2):555-63. doi: 10.1016/j.bbr.2010.11.058. Epub 2010 Dec 9. Behav Brain Res. 2011. PMID: 21145918 Review.
-
Interactions between beta-amyloid and central cholinergic neurons: implications for Alzheimer's disease.J Psychiatry Neurosci. 2004 Nov;29(6):427-41. J Psychiatry Neurosci. 2004. PMID: 15644984 Free PMC article. Review.
-
The significance of the cholinergic system in the brain during aging and in Alzheimer's disease.J Neural Transm (Vienna). 2006 Nov;113(11):1625-44. doi: 10.1007/s00702-006-0579-2. Epub 2006 Oct 13. J Neural Transm (Vienna). 2006. PMID: 17039298 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical